Presenting Author: – Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany; Charité-Universitätsmedizin Berlin, Berlin, Germany;
Primary Author: – Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany; Charité-Universitätsmedizin Berlin, Berlin, Germany;
Co-Author: – Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. Charité—Universitätsmedizin Berlin, Germany. DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany
Co-Author: – Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Co-Author: – Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.
Co-Author: – Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. Experimental and Clinical Research Center, Charite Medical Faculty and the Max Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Co-Author: – Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrueck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany